Importance 25
Marek's disease virus (MDV) causes an agro-economically important disease of chickens worldwide. 26 Although commercial poultry are vaccinated against MDV, it is not possible to achieve sterilising 27 immunity, and available vaccines can only protect chickens against the symptoms of the disease. 28
Vaccinated chicken often become superinfected with virulent strains, shedding virus into the 29 environment. The most effective MDV vaccine strain, CVI-988, shares >99% sequence identity with 30 the prototype virulent virus strain RB-1B. Interestingly, our work shows that despite their almost 31 identical sequences MDV strains CVI-988 and RB-1B have significantly different splicing profiles, and 32 hence transcriptomes. We independently validated this discovery by detecting with real-time PCR 33 some splicing isoforms expressed by MDV strain CVI-988 and absent in the transcriptome of the RB-34 1B strain. These results indicate that the coding potential of MDV might be much larger than 35 Introduction 38
Marek's disease (MD) is a major scourge of poultry, caused by Marek's disease virus (MDV, also 39 known as Gallid herpesvirus 2, GaHV 2), a member of genus Mardivirus in the subfamily 40
Alphaherpesvirinae of the family Herpesviridae. MD is characterised by paralysis, 41 immunosuppression, and lymphoid infiltration into different tissues, including the peripheral nerves, 42 eye, muscle and skin. Lymphoid tumours in the visceral organs can be observed as early as 3 weeks 43 post inoculation. Control of MD has been achieved by vaccination with the live attenuated oncogenic 44
Gallid herpesvirus 2 (MDV-1) strain CVI-988 (also known as Rispens) and the non-oncogenic 45 antigenically related vaccine viruses Gallid herpesvirus 3 (MDV-2) strain SB-1, and Meleagrid 46
herpesvirus 1 (herpesvirus of turkey, HVT) strain Fc126 (1-3). These vaccines were introduced at 47 different periods to control the disease caused by various MDV pathotypes. Today they are used 48 individually or more frequently in combination, since formulations including more than one vaccine 49
can have a synergistic effect that induces stronger protection against MD (4). However, despite 50 effectiveness of the single best vaccine (i.e. MDV strain CVI-988) in producing lifelong immunity 51
against clinical disease and mortality, all fail to produce sterilising immunity against MDV infection. 52
Vaccinated chickens can become infected with virulent MDV field strains -they show no obvious 53 clinical symptoms but shed virulent virus (5). In fact there has been a continuous evolution of MDV 54 virulence, with the emergence of hypervirulent pathotypes (6, 7) . A potential role of current vaccines 55 at driving virulence due to their inability to prevent infection and spread has been demonstrated (5). 56
As vaccinated birds are still susceptible to superinfection by more virulent MDV subtypes, co-57 infection with vaccine and pathogenic strains are common in clinical materials such as poultry house 58 dust (8) . 59 A puzzling feature of MDV genomics is the very high sequence similarity between the virulent and 60 vaccine strains. Despite the very different infection outcomes in vivo, the prototype virulent MDV 61 strain RB-1B and the most effective vaccine strain, CVI-988, differ by only about 1% of their 62 sequences. In fact the genomic differences between the RB-1B and CVI-988 strains are so limited 63 that only one DNA-based assay (9, 10) is available to differentiate between them; the assay relies 64 upon the detection of a few nucleotide substitutions localized to a single locus. Consequently, it 65 would look like the differences at DNA level are not the best proxy to understand why the two 66 strains behave so differently. 67 A much better vantage point might be represented by the viral transcriptome -for one thing, it has 68 already been shown in the past that a number of herpesviruses have an unsuspectedly rich 69 repertoire of RNAs (11) (12) (13) (14) . Detailed knowledge of the viral transcriptomes can also potentially shed 70 a much better light on the different mechanisms taking place during virus-host interaction. In fact 71 while our manuscript was under review, a study conducted by Betzbach and colleagues appeared in 72 press reporting novel genes and a comprehensive annotation of MDV in primary B cells inoculated 73 with BAC-derived MDV strains RB-1B or . Their study confirms that the community is 74 increasingly interested in better understanding the complexity of viral transcriptomes that arise as a 75 response to infection by closely related strains. 76
The work we report on here focuses on the differential expression of splice isoforms in CEF cells. Our 77 primary goal was to establish a way of distinguishing pathogenic MDV from the CVI-988 vaccine 78 strain by the detection of RNA transcripts differentially expressed by either strain in CEF cells. That 79 led to the discovery of pervasive strain-dependent splicing, with markedly different splicing isoforms 80 (spliceforms) expressed despite the fact that the two strains are closely related. To the best of our 81 knowledge, this is the first time that such a phenomenon is reported in the literature. In the work 82 presented here we have also directly validated in vitro, using a technique based on real-time PCR, 83 the differential expression of three splicing isoforms that are produced only by CVI-988. That 84 represents a solid starting point in order to be able to discriminate the infections by the two MDV 85 strains based on the differences between their transcriptomes. 86
Results

87
Briefly, we infected chicken embryo fibroblasts (CEFs) with two strains of MDV: virulent RB-1B and 88 the vaccine strain CVI-988. RNA was extracted from them, and a polyA-enriched fraction was used to 89 prepare complementary DNA (cDNA and are affirmed by this study. The localization of the introns on the MDV genome is presented in 105 Figure 1 (see tracks 4, 6, 8 and 10), where each solid bar represents a different intron. The direction 106 of splicing at acceptor/donor sites is indicated with a yellow arrow. 107 A number of positions appear to be alternative splice donors/acceptors, with several possible 108 corresponding introns being selected by the splicing machinery (see Figure 2 ). The likelihood of such 109 choice, which can be evaluated from RNA-sequencing data by comparing the coverage of the 110 different splice junctions, is highly variable -it can be very similar or very different depending on the 111 specific splice site. The distribution of splicing donors/acceptors is also not uniform across the whole 112 genome, but rather concentrated in some specific regions, especially the inverted repeats and, 113 surprisingly, the unique long region between 30 and 70kb (see Figure 1 and 3). 114
An interactive version of the data, presented as a genome browser, can be publicly accessed at 115 https://mallorn.pirbright.ac.uk/browsers/MDV-annotation/. 116 Splicing is strain-specific, and occurring more frequently in MDV strain CVI-988 117
Many splicing isoforms appear to be produced by both strains, as expected given their similarity in 118 nucleotide space. Despite this, one of our major findings is the identification of specific genomic 119 regions that encode a number of isoforms which are strain specific, at least in infected CEFs. 120
Examples are illustrated in Figure 2 , where the presence of different spliceforms within the 14 kD 121 locus is reported; in Figure 3 , showing how a much greater number of spliced introns is encoded in 122 the genome of MDV strain CVI-988 than those encoded in the genome of MDV strain RB-1B, 123 specifically on the negative strand of the UL region (coordinates 10-70 Kb); and in Figure 4 , which 124 reveals that this is not restricted just to the negative strand. Many similar examples of varying 125 splicing isoforms could be found throughout the MDV genomes, corroborating the observation that 126
the splicing patterns of MDV strains RB-1B and CVI-988 are significantly different, with much higher 127 levels of splicing occurring in CEFs infected by MDV strain Tentative reannotation of coding transcripts 129 In genomic regions with many consecutive multiple splicing donors/acceptors, such as the one 130 shown in Figure 3 , the combinatorics of alternative splicing are too complex to be solved with short 131 reads. However, it is possible to exhaustively enumerate all coding spliced transcripts compatible 132 with the introns observed. Here, we have taken such an approach to map sequences of putative 133
exons to all open reading frames which would translate into a protein longer than 35 amino acids 134 (see Materials and Methods) . It should be emphasised that some of such predicted coding 135 transcripts (in particular the more complex ones involving more than two exons) may not be present 136 at all, and confirming their presence experimentally is outside of the scope of this manuscript. 137
However, this tentative reannotation provides a fair representation of the splicing complexity at 138 different viral loci. Importantly, while our tentative reannotation only considers coding transcripts, 139 many more non-coding viral transcripts might potentially be found as well. 140
The reannotations can be accessed, and downloaded using the feature "Save track data", through 141 the genome browser mentioned above. Table 2 lists the number of putative coding spliceforms  142 annotated for a number of relevant MDV genes when CEF cells are infected by MDV strain RB-1B or 143
MDV strain CVI-988. In Figure 5 , we illustrate in more detail four cases. In panel A, we show splicing 144 events occurring in UL49/UL49.5 after infection by MDV strains RB-1B or CVI-988 (the latter event is 145 referred to as I1 in Table 3 ). Each splicing event is unique, and the nucleotide sequences of the two 146 spliceforms differ. In addition I1, the spliceform specific to MDV strain CVI-988, is present with 147 higher read coverage (Table 3) . Panel B describes 6 new possible splicing isoforms in the ICP4 gene 148 of MDV strain CVI-988. Additionally we observed more splicing events which could not be assigned 149
to the ICP4 gene itself as they were detected on the opposite strand. Panel C shows two new 150 putative splicing isoforms for pp14 occurring in both MDV strains (in addition to the two already 151 known) and another two novel ones occurring only in CVI-988. Panel D displays 14 novel splicing 152 events occurring at the UL52/UL53/UL54 loci in Our data confirms many MDV spliceforms previously reported in the literature. The splicing variant 154 which was reported (20) between the ORF011 and ORF012 genes of MDV can be found in our 155
RNASeq data -it is annotated on the genome browser as RB-1B-0865 or CVI-988-0883. In addition, 156
we observed both spliced variants of pp38 in CEF cells infected with MDV strain RB-1B (RB-1B-0918 157
and RB-1B-0919 according to the nomenclature used in our reannotation) and one spliced variant of 158 pp38 in cells infected with CVI-988 (CVI-988-0979). In the gC region, we observed the two previously 159 described splicing transcripts (19): namely RB-1B-0874 and RB-1B-0875; or CVI-988-0920 and CVI-160 988-0921 in RB-1B and CVI-988 infected CEFs, respectively. Additionally, we observed three further 161 novel spliced isoforms -RB-1B-0933, RB-1B-0876, and RB-1B-0877 in CEFs infected with the RB-1B 162 strain; and CVI-988-1051, CVI-988-0922, and CVI-988-0923 in CEFs infected with strain CVI-988. We 163 observe a higher diversity in transcripts of the ICP4 gene in cells infected with MDV strain CVI-988 164 than in cells infected with MDV strain RB-1B. 165
Although our data confirms many known spliceforms of MDV, we could not identify all of them. For 166 example, we could not observe the spliceform between Meq and vIL8 loci which was described as 167 meqΔC-BamL in MSB-1 cells or infected CEF cells (16, 23) . Unlike other previous reports (17), we only 168 observed one unspliced product for the Meq protein. In the IL8 region, we did not observe 169 RLORF4/IL8 or RLORF5/vIL8 related transcripts (17). According to our data, an alternative start codon 170 in vIL18 region could be employed to produce a novel transcript for vIL8 made of exons I and II of the 171 gene, but representing an overlapping ORF (RB-1B-0928 or CVI-988-1019) to the main ORF of vIL8 172
(RB-1B-0936 or CVI-988-1068). In the vIL8 region, splicing between exon I and exon II would produce 173 a shorter transcript than the full vIL8 transcript, with a length of 379 nucleotides and containing an 174 immature stop codon at the end of the second splice site (RB-1B-0929 or CVI-988-1020). 175
Selection of strain-dependent introns 176 By comparing the coverage in spliced reads at the same genomic positions between virulent (RB-1B) 177
and vaccine (CVI-988) MDV strains, a list of viral introns showing the highest variation between 178 strains was generated (Table 3 , see Materials and Methods for a description of the procedure used). 179
According to this coverage-based ranking and feasibility of real-time PCR probe design, three introns 180 that were exclusively spliced in the CVI-988 transcriptome (indicated in Table 3 as I1, I2, and I3) were 181 selected for further study. Introns I1 and I2 are highlighted in Figure 4 , while intron I3 can be found 182
in Figure 3 . 183
The kinetics of I1 expression in CEFs transfected with MDV strains CVI-988 and RB-1B
184
In order to determine the time window during which I1 was transcribed from the MDV genome, its 185 time-dependent expression was subsequently determined using qRT-PCR on RNA isolated from CEFs 186 infected with both MDV strains RB-1B and CVI-988. MDV is avidly cell associated, which makes it 187 problematic to achieve synchronised expression of viral transcripts due to in vitro growth differences 188 between attenuated CVI-988 and virulent RB-1B. Hence the time course experiment was performed 189 by transfecting CEFs with equimolar amount of recombinant bacterial artificial chromosome (BAC) 190
containing the complete genomes of MDV strains CVI-988 and 25) . Expression levels were 191 assessed from transfected cells harvested at nine different time points ranging from 0 to 90 hours 192 post transfection, using GAPDH as a reference for relative quantitation (Figure 6 
panel B). 193
Intron l1 is expressed at roughly equal levels in both MDV strains RB-1B and CVI-988 infected cells 194 until 54 hours post transfection (the baseline being that GAPDH is about 4x10 6 times more expressed 195 than I1). However, starting from 66 hours post transfection the expression of I1 progressively 196 increases (with differences becoming statistically significant) in cells transfected with MDV strain 197 CVI-988. The peak is recorded at 90 hours post transfection, when the expression level is about 100 198 times greater in cells transfected with MDV strain CVI-988 than in cells transfected with MDV strain 199 RB-1B. This finding agrees with the earlier observation deduced from RNA-sequencing data that at 3 200 days post infection, and increasingly so, I1 is expressed at exceedingly greater levels in CEFs infected 201
by CVI-988 than in cells infected by RB-1B, making I1 a good candidate marker to discriminate 202 between the two strains. A viral transcript was used to assess transfection efficiency, and its level 203 was similar in CEF cells transfected with either of the strains (data not shown). 204
I1 is detectable even at low viral loads 205
The expression differentials just described remain true at 5 days post infection across a wide range 206 of virus infectious loads. The expression levels of I1 were quantified using relative RT-PCR with RNA 207 isolated from 1.3x10 6 CEF cells infected with 1,000, 100 or 10 PFU of MDV strains RB-1B or CVI-988 208 in 9 cm 2 tissue culture dishes ( Figure 6 panel A) -due to the cell-associated nature of MDV, we were 209
unable to calculate MOI. The following lists the results: 210 1. The expression of the housekeeping gene, GAPDH remained unchanged at a 40-Ct value of 211 ~18 across the different PFU levels (p = 0.48 based on a two-way repeated measures ANOVA 212 test) and independent of the strain. 213
2. In CEFs infected by MDV strain CVI-988 the levels of expression of I1 also correlated very 214 well with inoculum titres (Pearson's r 0.98, p-value 6.1x10 -6 ) and I1 was detectable across 215 the whole PFU range. 216
3. I1 expression was undetectable in 1.3x10 6 CEFs infected with 100 or 10 PFU of MDV strain 217 RB-1B. In cells infected with 1,000 PFU I1 levels were still extremely low (averaged 40-Ct 218 value 2.4). 219
Overall, our results support the use of intron I1 as a biomarker across a wide range of viral titres. 220
Whenever it should be detectable -i.e. in CEFs infected by MDV strain CVI-988 starting from roughly 221 60 hours post infection -it remains so even at very low virus input, and its abundance at 5 days post 222 infection in vitro shows a very clear and predictable linear relationship with virus input. We assumed 223 that these findings would be generalizable to I2 and I3. 224 Differential expression of I1, I2, and I3 in MDV strains RB-1B and CVI-988
225
At 5 days post infection all our three candidate introns (I1, I2, and I3) are differentially expressed in 226
CEFs infected with MDV strains RB-1B and CVI-988. Such differential expression can be quantified 227 using GAPDH as PCR calibrator. 228
Briefly, in order to precisely calculate expression levels, standard curves using PCR-amplified or 229 cloned fragments of DNA representing I1, I2, I3, and GAPDH were first made and used to calculate 230 PCR efficiency. Each amplicon was Sanger sequenced in order to confirm that the sequence 231
identified by PCR corresponded with that of the splice junction predicted from RNA-sequencing data. 232
The expression levels of the three biomarkers (I1, I2, I3) in CEFs infected by MDV strains RB-1B or 233 CVI-988 at 5 days post infection (N=6) were computed and normalised against GAPDH, in order to 234 achieve accurate calibration. Fresh virus stock obtained after only two passages was used for 235 infection for both strains. Full details are described in Material and Methods. 236
The results are presented in Figure 7 , and represent one of the main outcomes of this paper. When 237 comparing expression in CEFs infected with MDV strain CVI-988 to expression in CEFs infected with 238 MDV strain RB-1B, the greatest fold-change was observed for intron I1, which appeared to be 239 expressed ~2800 times more when GAPDH was used as a calibrator. I2 and I3 exhibit fold-changes 240 that are lower than those of I1 but still easily measurable and statistically significant (I2 vs. GAPDH: 241 6.3; I3 vs. GAPDH: 5.3) confirming the ranking originally deduced from RNA-sequencing data (Table  242 3). 243
Discussion
244
The pathobiology of Marek's disease virus is complex (26). This alphaherpesvirus is able to infect 245 chicken cells and cause tumours in a wide variety of tissues. The outcome is that virions are shed 246
into the environment as infectious dander (5) is involved in cell cycle arrest, virus spread and histone association during MDV replication in vitro 278 (32) . Further studies will be required in order to investigate the involvement of the I1 transcript in 279 the interaction between virus and host. 280
One should note that there are limitations to the sensitivity of the technique we employed in this 281 study -in particular, spliceforms that are too weak with respect to the most abundant RNA species 282
will not be detectable, depending on the number of sequencing reads generated during the 283 experiment. In fact, as described in the Results section, a number of splicing isoforms identified in 284 previous studies by qPCR could not be found in our data. Whether this is due to limited sensitivity or 285 to the fact that such isoforms are specific to other experimental conditions -for instance, (23) used 286 MSB1 cells rather than CEFs -the conclusion can only be that the potential size of the MDV 287 transcriptome is even larger than what emerges from our study. That is confirmed by the novel 288 transcripts identified in (15). Again, this is entirely similar to what can be seen for other 289 herpesviruses -in previously studied CMV infected cells, the authors were unable to identify some 290 of the previously annotated genes (13). 291
Further complementary investigations based on long-read technologies (e.g. Pacific Biosciences) will 292 also be required to fully resolve the genomic structure of long spliced transcripts being made of 293 many consecutive exons. 294
Even more interestingly, a significant number of viral splicing isoforms of MDV strains CVI-988 and 295
RB-1B appear to be strain-specific, despite the high sequence similarity (>99%) between the two 296 strains. We validated this finding by using a Taqman-based assay. The assay was proven to be 297
reproducible. As far as we know such a striking result had not been previously reported in the 298 literature, and it is not reported in (15) either. Not surprisingly, our preliminary analysis of the host 299 transcriptome (data not shown) indicates that the splicing of host transcripts also depends on the 300 virulence of the infected strains. We point out that the effect we notice cannot be ascribed to 301 culture adaptation -as explained in the Material and Methods section, both MDV strainRB-1B and 302
MDV strain CVI-988 stocks we used underwent only two passages before being used for infection. 303 Likewise, what we observe cannot be explained away by the known fact that splicing tends to be 304 highly unregulated in tissue culture cells for most herpesviruses, including MDV (17) -even in the 305 presence of an equally permissive environment for splicing, MDV strain RB-1B appears to produce a 306 much more limited number of splicing isoforms across the genome than MDV strain CVI-988. It is 307 possible that the greater propensity for splicing exhibited by MDV strain CVI-988 indirectly derives 308 from the fact that its attenuation was obtained by repeated passaging the strain in cell culture, but 309 by now the trait has apparently been fixed in its genome, which is an interesting biological fact. 310
Taken together, our results suggest the possibility that different MDV strains might interact 311 differently with the splicing machinery of the host; a different interaction of the spliceosome and 312 associated proteins with the MDV genome in CEFs infected by the strain CVI-988 might result in a 313 much richer splicing landscape. However, it is not possible at this stage to pinpoint the responsible 314 for such differences at a molecular level -for instance, in the ICP27 region our data shows similar 315 splicing patterns for MDV strain RB-1B and strain CVI-988 (with only one intron present in the strain 316 CVI-988 and not in the strain RB-1B) and no differential expression (corrected p-value for differential 317 expression computed by edgeR = 0.65), so it is unclear at the moment whether ICP27 might be 318 responsible for what we observe. 319
As the results of RNA-sequencing describe the averaged collective nature of a relatively large 320 number of infected cells, it is hard to say whether those differences are typical of every infected cell 321 or just a smaller sub-population. In order to truly reveal the complexity of alternative splicing across 322 diverse cell and tissue types, in future studies it might be prudent to sequence the RNA 323 transcriptome of individual cells, especially from tissues (e.g. lymphocytes, tumours, FFE, etc.) of 324 experimentally infected birds, and use proteomics to determine whether splice-variant transcripts 325 are translated into protein products or just have RNA regulatory functions. We also plan to define 326 the virus transcriptome in various tissues isolated from vaccinated/challenged bird that that are 327 susceptible and resistant to Marek's disease. That might help elucidate the molecular mechanisms 328
underlying the diversity that we observe in splicing landscapes. 329
Overall, the data presented in this report suggest the presence of a large number of spliced viral 330 transcripts in infected CEFs, allowing us to identify spliceforms that contain introns exclusive to the 331 MDV strain CVI-988. Building upon such findings we have also designed primers and probes that can 332 specifically detect such transcripts, thus effectively differentiating in CEFs the transcriptome of MDV 333 strain CVI-988 from that of strain RB-1B. To the best of our knowledge, this study is the first one ever 334
to propose a technique based on the differential detection of splicing events. 335
Obvious questions to be elucidated in the future are whether our results can be extended to other 336 tissues/MDV strains; and whether differential expression of I1-I3 (or possibly other spliceforms yet 337 to be identified) can also be detected in vivo. 338 Acknowledgements 339
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throughput sequencing was performed by ATA. stock and used for RNA isolation, as described in the next section. MDV strain CV-I988 was prepared 359 from CEF cells with two passage history after they were infected with Nobilis Rismavac vaccine virus. 360
The passage 2 virus stock was used for RNA isolation, as described below. 361
Sample preparation 362
Confluent CEFs in a 75 cm 2 flask (8.0 X 10 6 cells in each flask) were infected with 1500 pfu of CVI-988 363 or RB-1B virus in DMEM containing 5% FBS and the antibiotic streptomycin (100μg/ml) and penicillin 364 (100U/ml). 365
The flasks were incubated for five days at 37⁰C in 5% CO2 and RNA was isolated using Trizol 366 (Ambion) according to the method described by the manufacturer. For each biological condition 367 (CEFs infected with MDV RB-1B very virulent strain; and CEFs infected with MDV CVI-988 vaccine 368 strain) two biological replicates were selected. 369
Sequencing
370
RNA samples were sequenced at the Centro Nacional de Análisis Genómico (Barcelona, Spain Analysis (RTA 1.13.48) and were followed by generation of FASTQ sequence files with CASAVA 1.8. 382
For this analysis the two biological replicates available for each MDV strain (RB-1B and CVI-988) were 383 pooled together prior to analysis, in order to increase the overall read coverage. 384
Bioinformatics selection of biomarkers 385
Primary analysis 386 Reads were subjected to preliminary quality control and processed with a workflow for primary data 387 analysis based on the GEM mapper (33) which is an evolution of the method used to process the 388 data produced by the GEUVADIS consortium (34). Contrary to other methods relying on accurate 389
annotations, this one includes a highly sensitive de-novo intron detection step. This feature enabled 390 accurate alignments in spite of errors or limitations in the available annotation of cellular transcripts, 391
and an unbiased picture of splicing in different MDV strains. 392
It should be noted that separately aligning MDV RB-1B reads to the RB-1B genome and MDV CVI-988 393 reads to CVI-988 would have not been possible for this analysis, as during subsequent stages we 394 needed to compare coverage of the same intron across different viruses. In order to be able to do 395 so, reads from samples infected with different viruses (MDV strains RB-1B and CVI-988) were all 396 aligned to the same MDV MD5 reference (NCBI accession number AF243438). Although in principle 397 this procedure might decrease the amount of reads successfully mapped and potentially introduce 398 artefacts, in practice it works well due to the high sequence similarity of the strains involved in the 399 experiment -the conclusions presented in the paper are qualitatively identical when reads from 400 both infections (RB-1B and CVI-988) are aligned to either MDV strains (MDV strain RB-1B, NCBI 401 accession EF523390, or MDV strain CVI-988, accession DQ530348). As a relevant fraction of MDV 402 genome is replicated twice -see for instance Figure 1 , where mappability (35) for the genome is 403
shown -reads aligning to more than one location of the genome were assigned to all locations, with 404 normalisation 1/(number of alignments). Keeping only uniquely mapping reads, as is often done in 405
RNA-seq data analysis, would have resulted in complete loss of signal in the repeated regions of the 406 virus. 407
Tentative annotation of full spliced coding transcripts 408
The workflow used for primary analysis of each sample generated a list of introns, each one 409 annotated with the number of spliced reads covering it. Introns having a coverage of 10 reads of 410 more were kept, candidate exons were deduced from them, and an in-house script was used to 411 generate all possible coding sequences of exons compatible with translation start and end signals 412 present in MDV genome. Only putative transcripts leading to protein sequences longer than 35 413 amino acids were kept. This step was performed separately for the RB-1B and the CVI-988 data. 414
Selection of relevant MDV encoded introns 415
The intron list obtained after primary analysis was also split based on the following criteria: (i) viral 416
introns that have a sufficient read coverage in CEFs infected with MDV strain RB-1B, and no coverage 417
in CEFs infected with strain CVI-988; (ii) viral introns having sufficient read coverage in CEFs infected 418 with strain CVI-988, and no coverage in CEFs infected with strain RB-1B. Introns were considered to 419 be sufficiently populated whenever they had non-zero coverage in all biological replicates and the 420 sum of their coverage across all replicates was ≥ 20 (arbitrary threshold). Finally, the list of introns 421 was prioritised based on the geometric mean of the coverage in spliced reads across all replicates. 422
An arbitrary final minimum threshold of 25 was used for the mean, in order to exclude from the list 423 candidates with low level expression. 424
Differential expression of transcripts 425 The differential expression for ICP27 mentioned in the Discussion was computed using edgeR (36) 426 version 3.20.9. 427
Data visualisation 428
The genome browser is based on a customised version of JBrowse (37). 429
In-vitro validation of the internal RT-PCR control, GAPDH 430 Sample preparation 431 MDV strain RB-1B and CVI-988 were propagated as previously described (9, 10). To prepare samples 432 for real time PCR, CEFs were infected in 9.8 cm 2 wells (6 well plates, 1.3x10 6 cells in each well) with 433 500 pfu of MDV strains RB-1B or CVI-988. Uninfected and infected cells were harvested for RNA 434 purification using Trizol reagent (Ambion) as described by the manufacturer. 435
For the time course experiment, semi-confluent CEFs (80%) were transfected with 1 g of RB-1B or 436 CVI-988 BAC DNA clone using 10 l of lipofectamine transfection reagent (Life Technologies) in 9.8 437 cm 2 tissue culture plates. Three independent transfection was conducted to have 3 replicates (N=3). 438
At 6 , 12, 18, 30, 42, 54, 66, 87 and 90 hours post transfection, CEFs were harvested from the plates, 439
washed with PBS, suspended in RLT buffer (Qiagen) and stored at -80°C until the time of RNA 440 purification. RNA was isolated using RNeasy (Qiagen) and the contaminating DNA was destroyed by 441
DNaseI treatment (New England Biolabs). cDNA was synthesized using RevertAid H minus reverse 442 transcriptase (ThermoFisher Scientific) with random hexamers. Real-time PCR for I1 and GAPDH was 443 conducted as described in (10, 38) . 444
Primers and probes 445
Primers and probes were designed for each splicing isoforms using the PrimerQuest tool provided by 446
Integrated DNA Technologies (IDT). Each probe was designed to span the splice junction, to avoid 447 non-specific interaction between closely related splice variants. A list of primers and probes, sizes of 448 the amplicons, and location of targeted introns is provided in Supplementary Table 3 . GAPDH was 449 used as the host gene. A pair of primers and a probe for the splice junction between exons 5 and 6 450 was designed to be used to detect the level of GAPDH cDNA. Each probe was labelled with 5'FAM 451 reporter, ZEN™ and 3'-BHQ1 quenchers (Integrated DNA technology, IDT). 452
Relative quantitative RT-PCR
453
Real time qRT-PCR was performed using ABsolute blue qPCR mix (Thermo Scientific), primer pairs 454 (each 0.4 uM) and probe (0.2 uM) for the splice junctions of interest. To generate a standard curve, 455 splice junction amplicons were cloned in pGEM-T plasmid (Promega) and subjected to Sanger 456 sequencing. Ten-fold serial dilutions were prepared to produce a range from 1 nM to 10 fM. Every 457 real-time PCR run included, specific primers and probe for one of the splice junctions, the primers 458 and probes for GAPDH, and the primers and probe for the virus control and were performed in 459
triplicates. The reaction were processed on a 7500 Fast Real-time PCR system (Applied Biosystems) 460 with reaction conditions specified by the master mix manufacturer. Data was collected and analysed 461 using 7500 Software (v2.3, Applied Biosystems). 462
Accession numbers 463
The raw sequencing reads have been deposited into the NCBI Sequencing Read Archive (SRA) under 464 the project accession number PRJNA541962. The files corresponding to CEF cells infected with RB-1B 465
and CVI-988 strains, each in two replicates, can be downloaded as accession numbers SRR9030404, 466 SRR9030405, SRR9030406, and SRR9030407. 467 
